drug

PEP-CMV

updated 3mo ago

by National Cancer Institute US

community read0 votes

🐶 often sniffed alongside

top 3

all catalysts(1)

phase 1 2 initiation · 1

Apr 30, 2026

phase 1 2 initiation

4mo ago

National Cancer Institute US — PEP-CMV (Phase I/II Trial Initiation)

PEP-CMV

→

Trials studying PEP-CMV

phase2PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymomasuspendedn=68

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 10m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

PEP-CMV

updated 3mo ago

by National Cancer Institute US

community read0 votes

🐶 often sniffed alongside

top 3

all catalysts(1)

phase 1 2 initiation · 1

Apr 30, 2026

phase 1 2 initiation

4mo ago

National Cancer Institute US — PEP-CMV (Phase I/II Trial Initiation)

PEP-CMV

→

Trials studying PEP-CMV

phase2PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymomasuspendedn=68

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 10m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

PEP-CMV

🐶 often sniffed alongside

all catalysts(1)

Trials studying PEP-CMV

News(0)

Report a data issue

comments(0)

PEP-CMV

🐶 often sniffed alongside

all catalysts(1)

Trials studying PEP-CMV

News(0)

Report a data issue

comments(0)